Asia Pacific mHealth market is estimated to register a high CAGR of 35.8% during the forecast period of 2015-2020, according to a new report published by Allied Market Research. In 2014, blood pressure monitors, blood glucose monitors and cardiac monitors collectively accounted over two-thirds share in the Asia-Pacific mHealth device marketand would continue to dominate throughout the forecast period. China was the largest country market in the Asia Pacific region and is expected to maintain its dominant position during the forecast period. Factors such as growing population, rising disposable incomes and a large presence of local manufacturers would boost the market growth.
List of Key Players
Key players profiled in this report include – Philips healthcare, Omron HealthCare Inc., Bayer Healthcare, LifeWatch, Masimo Corporation, Sanofi, Boston Scientific, AT&T Inc., and Johnson & Johnson.
Download Sample Report: https://www.alliedmarketresearch.com/request-sample/1173
Key Findings Of The Study
In 2014, mobile operators segment held a dominant shareinthe Asia Pacific mHealth market by stakeholders.
Blood glucose meters segment is projected to register the fastest growth rate in the Asia Pacific mHealth devices market, registering a CAGR of 44.4% during the forecast period.mhealth market.
Among all geographies, India is projected as one of the most lucrative markets, registering a CAGR of 42.6%
In 2014, Cardiovascular application segment held leading position in the overall
For Purchase inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1173
In the Asia-Pacific mHealth services market, monitoring was the largest revenue generating segment, accounting for about half of the mHealth services market share in 2014. Key factors responsible for the growth of Asia Pacific mHealth services market include increasing government initiatives, growing awareness among patient population among others.